Rolf H. Henel, Director at SCICLONE PHARMACEUTICALS INC (SCLN), bought 29,400 shares at $1.79 ($52K) on 2008-05-13, disclosed to the SEC on 2008-05-15.
Open-market purchase of $52k SCLN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 4,300 | $8K | 14.4% |
| 2 | $1.75 | 5,000 | $9K | 16.7% |
| 3 | $1.79 | 5,000 | $9K | 17.1% |
| 4 | $1.80 | 5,000 | $9K | 17.2% |
| 5 | $1.80 | 5,100 | $9K | 17.5% |
| 6 | $1.80 | 5,000 |
| $9K |
| 17.2% |
| Total | $1.78 avg | 29,400 | $52K | 100% |
| Filing → |
| SCLN | BUY | 2007-11-23 | $1K | — | Filing → |